Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States

Leah R. Koenig, Elizabeth G. Raymond, Marji Gold, Christy M. Boraas, Bliss Kaneshiro, Beverly Winikoff, Leah Coplon, Ushma D. Upadhyay

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Objective: Given the substantial barriers to abortion access in the United States, many clinics now mail patients abortion medications. We examined whether dispensing the medications by mail prolonged time to medication use. Study design: We analyzed data from no-test medication abortions with medication provided either by mail or in a clinic from 11 United States clinics from February 2020 to January 2021. We examined mean number of days from patients’ first contact with the clinic to mifepristone ingestion, its two-component intervals (first contact to medication dispensing and dispensing to mifepristone ingestion), and pregnancy duration at mifepristone ingestion. We used Poisson regression to compare mean outcomes across three dispensing methods: in-person, mailed from the clinic, and mailed from a mail-order pharmacy. Results: Among the 2600 records, patients took mifepristone on average at 49 days of gestation (95% CI, 47–51) and 7 days (95% CI, 4–10) after first contact. Mean time from first contact to mifepristone ingestion was 6 days when medications were dispensed in-person and 9 days when mailed (p = 0.38). While time from first contact to dispensing was similar across methods (6 days in-person, 5 days mailed, p = 0.77), more time elapsed from dispensing to mifepristone ingestion when medications were mailed (4 days from clinic, 5 days from mail-order pharmacy) versus dispensed in-person (0.3 days, p < 0.001). Time to mifepristone ingestion was shorter with higher pregnancy duration. Pregnancy duration at ingestion was similar across methods (48 days in-person, 50 days mailed). Conclusions: Mailing medications did not significantly prolong time from patients’ first contact with the clinic to mifepristone ingestion or increase pregnancy duration at mifepristone ingestion. Implications: Abortion providers should offer a range of medication abortion dispensing options, prioritizing patient preference.

Original languageEnglish (US)
Article number109962
JournalContraception
Volume121
DOIs
StatePublished - May 2023
Externally publishedYes

Keywords

  • Mailing
  • Medication abortion
  • Mifepristone
  • Pharmacy
  • Risk Evaluation and Mitigation Strategy (REMS)
  • Telehealth

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States'. Together they form a unique fingerprint.

Cite this